Navigation Links
Drug Firm Disowns Liability

The German biotech firm TeGenero, the drugs company behind the clinical trial listed its potential side effects on its 12-page document prepared by Parexel. //This consent form listed a side effect which can seriously harm the immune system. The clinical trial left six volunteers fighting for their lives. The consent form the men were asked to sign, which has been obtained by The Observer, warned that a possible effect of the drug was cytokine release. This includes a massive immune reaction to a chemical as it triggers an uncontrollable response from antibodies.

It is otherwise called as a cytokine release or cytokine storm. This can be life-threatening but the form does not spell that out. It is also doubtful whether the doctor heading the trial at Northwick Park Hospital in north London verbally highlighted the specific nature of the cytokine risk to the participants. The form says that that the drug could cause a hives-like allergic reaction. The volunteers were struck down with symptoms within minutes of being injected with the drug. A string of possible side effects are listed on the form, revealed for the first time in this newspaper. The consent form says that the participants may not experience any side effects as the doses used in early human studies are always very small.

But sometimes unintended effects may be encountered during any trial with a monoclonal antibody drug, though they did not occur even at the highest tested doses in animals. The various side effects listed are immunosuppression, autoimmunity, cytokine release, and anaphylaxis. Even the Medicines and Healthcare Products Regulatory Agency (MHRA) which authorised the trial was notified beforehand that there was this risk of cytokine release. The study obtained approval from German and UK authorities.


'"/>




Page: 1

Related medicine news :

1. Ex-workers Ask HLL to Accept Liability for Mercury Deaths

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Firm Disowns Liability

(Date:11/21/2009)..., WASHINGTON, Nov. 21 ...ent after the Senate voted to begin full debate of...: http://www.newscom.com/cgi-bin/prnh/20080519/DN...storic step on the road to enacting health insuran...e, senators will now have an opportunity to debate...
(Date:11/21/2009)..., WASHINGTON, Nov. 21 ...iminate onchocerciasis (river blindness) in the Am... the disease in recent years, as evidenced by a 31...mass drug administration in six endemic countries....eeting of the American Society of Tropical Medicin...
(Date:11/21/2009)... NH based medical credentialing so...ts industry to form a partnerhsip with Amerinet, I...is partnership will help to transform quality care... (Vocus) November 21, 2009 -- ISG Group, LL...ced a new agreement with Amerinet Inc., a leading ...
(Date:11/21/2009)... Eric J. Hall, president and chief...f America (AFA) issued the following statement reg...tion as part of the new annual wellness for Medica...nd Affordable Care Act" that was introduced l... (PRWEB) November 21, 2009 -- Eric J. Hall, presid...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understanding B... Dr. Jeremy Schmahmann,...and neurologist at the Massachusetts General Hospi... his laboratory,s research on the new field of stu...link Foundation. ,, Dr. Schmahmann is an award-...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
... one resource the necessary information to make an...r, at any time of year , , LYNDHURST, N.J., D...ifying the city,s best otolaryngologist (and figur...y the ABMS. As the leading online doctor evaluati...
...TRIANGLE PARK, NC, Dec. 10 /PRNewswire-FirstCall/ ...elopment and manufacturing services to the interna...nce the opening of its new U.S. headquarters and a...nd, Research Triangle Park has evolved into an int...
...de national contracting portfolio, e-commerce exch... Dallas (Vocus) December 10, 2008 -- Broadlane...ymouth, Massachusetts has selected Broadlane as th...tems will access Broadlane,s unparalleled national...
...t and MDS Pharma Services, Goodwill, , , T...(TSX: MDS; NYSE: MDZ ), a leading provider of pr...rkets, today provided an update for fiscal 2008 pe...on and adjusted EBITDA in the range of $148 millio...
...tock Purchase Rights , , TUCSON, Ariz., Dec. ... PRSC ) today announced that its Board of Director...h all of its shareholders will receive rights to p... term valuations are not reflective of historical ...
... Shows Remarkable Quick Weight Loss Improvement , ...a 104 pound, 7-year-old, Labrador retriever, and h...,s PetFit(TM) Challenge participants. At Zeb,s re...s to a combination of a thorough veterinary health...
Other Medicine News:Health News:Vitals Launches Free eBook to Help Consumers Find 'Dr. Right' 2Health News:Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC 2Health News:Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC 3Health News:Jordan Health Systems Selects Broadlane to Provide Comprehensive Supply Chain Services 2Health News:Jordan Health Systems Selects Broadlane to Provide Comprehensive Supply Chain Services 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Providence Service Corporation Adopts Shareholder Rights Plan 2Health News:Providence Service Corporation Adopts Shareholder Rights Plan 3Health News:Video: Combined Veterinary and Pet Owner Efforts Help Pet Lose Big 2Health News:Video: Combined Veterinary and Pet Owner Efforts Help Pet Lose Big 3
(Date:11/19/2009).../ -- In response to an ever-increasing number of w... Operation Pangea II, involving 24 countries, was ...ization,s International Medical Products Anti-Coun...gers of buying medicines online. ,, The week lo...ts and the seizure of thousands of potentially har...
(Date:11/19/2009)... -- Riverain Medical announced today that the comp...al imaging distributor Christie Group to offer Sof...y CAD. The exclusive agreement will bring Dayton, ...dian market through Christie Group,s established a...d Chest Imaging increases the clarity of digital c...
(Date:11/19/2009)...t Week of Action ,, SILVER SPRING, Md., Nov. 1...g Administration today completed a coordinated, we...onal Internet Week of Action (IIWA), intended to c..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...s Office of Criminal Investigations (OCI), in conj...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6CyberKnife Center of Miami Executive Director James G Schwade M D Garners Ultimate Miami CEO Award 48158 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 2Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 3
...chieved Based on Compelling Clinical Studies - ... July 15, FREMONT, Calif., June 25 Vermillion, I...any, today announced that it,has submitted a 510(k...Food,& Drug Administration (FDA) requesting regula...own as OVA1(TM)., As announced previously, the OV...
... CEO Neil Kurtz, M.D., to Moderate Discussion, Fol...Goldstein, M.D.; and Alan ...binar hosted by,TorreyPines Therapeutics, Inc. (Na... together industry experts to discuss the opportun...spasticity through the inhibition of the,neurotran...
Other Medicine Technology:Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test 2Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test 3Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test 4TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 2TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 3TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 4
Small Joint Arthroscopy Hand Instrument Set
...assive Tendon Implants are indicated for use in st.... James M. Hunter for the reconstruction of flexor...icant hand tendon injury.The device is intended to...e formation of pseudosynovial sheath which will la...
Silicone MCP
NeuFlex™ MCP/PIP Finger Joint Implant Systems
Medicine Products: